Elevance falls after annual profit forecast cut, Q2 profit miss

** Shares of health insurer Elevance Health ELV.N fall 8.1% to $315 premarket

** Co trims annual profit forecast to about $30 per share, compared with a previous projection of $34.15 to $34.85 per share, analysts on average were expecting $34.23, according to data compiled by LSEG.

** ELV reports Q2 adj. profit of $8.84 per share vs analyst est. of $8.95 per share

** Co posts Q2 operating revenue of 49.4 billion, surpassing analysts' average estimate of $48.23 billion

** Reports Q2 medical loss ratio, which is the percentage of premium spent on medical care, of 88.9% vs estimates of 88.7%

** As of last close, ELV stock was down 6.6% YTD